Logo image of AVCO

AVALON GLOBOCARE CORP (AVCO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AVCO - US05344R1041 - Common Stock

0.5259 USD
-0.1 (-16.52%)
Last: 11/9/2022, 8:00:00 PM
0.601 USD
+0.08 (+14.28%)
After Hours: 11/9/2022, 8:00:00 PM
Fundamental Rating

0

AVCO gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. AVCO may be in some trouble as it scores bad on both profitability and health. AVCO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AVCO has reported negative net income.
AVCO had a negative operating cash flow in the past year.
AVCO Yearly Net Income VS EBIT VS OCF VS FCFAVCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -5M -10M -15M

1.2 Ratios

Industry RankSector Rank
ROA -82.31%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVCO Yearly ROA, ROE, ROICAVCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 500

1.3 Margins

Industry RankSector Rank
OM -556.86%
PM (TTM) -600.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AVCO Yearly Profit, Operating, Gross MarginsAVCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -200 -400 -600 -800 -1K

More info and screens

0

2. Health

2.1 Basic Checks

AVCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AVCO has more shares outstanding
AVCO has a better debt/assets ratio than last year.
AVCO Yearly Shares OutstandingAVCO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
AVCO Yearly Total Debt VS Total AssetsAVCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M

2.2 Solvency

AVCO has an Altman-Z score of -7.78. This is a bad value and indicates that AVCO is not financially healthy and even has some risk of bankruptcy.
AVCO has a Debt/Equity ratio of 14.00. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 14
Debt/FCF N/A
Altman-Z -7.78
ROIC/WACCN/A
WACC8.18%
AVCO Yearly LT Debt VS Equity VS FCFAVCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 5M -5M 10M

2.3 Liquidity

AVCO has a Current Ratio of 0.23. This is a bad value and indicates that AVCO is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.23 indicates that AVCO may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
AVCO Yearly Current Assets VS Current LiabilitesAVCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 1M 2M 3M 4M 5M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.93% over the past year.
AVCO shows a small growth in Revenue. In the last year, the Revenue has grown by 5.16%.
Measured over the past years, AVCO shows a quite strong growth in Revenue. The Revenue has been growing by 17.67% on average per year.
EPS 1Y (TTM)27.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.38%
Revenue 1Y (TTM)5.16%
Revenue growth 3Y-3.8%
Revenue growth 5Y17.67%
Sales Q2Q%3.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AVCO Yearly Revenue VS EstimatesAVCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 500K 1M 1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVCO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVCO Price Earnings VS Forward Price EarningsAVCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -6.4
AVCO Per share dataAVCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVCO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVALON GLOBOCARE CORP

NASDAQ:AVCO (11/9/2022, 8:00:00 PM)

After market: 0.601 +0.08 (+14.28%)

0.5259

-0.1 (-16.52%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-15 2022-08-15
Earnings (Next)11-22 2022-11-22/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners66.28%
Ins Owner Change0%
Market Cap46.82M
Revenue(TTM)1.41M
Net Income(TTM)-8.46M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 33.22
P/FCF N/A
P/OCF N/A
P/B 268.62
P/tB 268.32
EV/EBITDA -6.4
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.02
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -82.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -556.86%
PM (TTM) -600.07%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.68%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z -7.78
F-Score4
WACC8.18%
ROIC/WACCN/A
Cap/Depr(3y)40.65%
Cap/Depr(5y)947.47%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.16%
Revenue growth 3Y-3.8%
Revenue growth 5Y17.67%
Sales Q2Q%3.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.72%
OCF growth 3YN/A
OCF growth 5YN/A

AVALON GLOBOCARE CORP / AVCO FAQ

What is the ChartMill fundamental rating of AVALON GLOBOCARE CORP (AVCO) stock?

ChartMill assigns a fundamental rating of 1 / 10 to AVCO.


What is the valuation status for AVCO stock?

ChartMill assigns a valuation rating of 0 / 10 to AVALON GLOBOCARE CORP (AVCO). This can be considered as Overvalued.


Can you provide the profitability details for AVALON GLOBOCARE CORP?

AVALON GLOBOCARE CORP (AVCO) has a profitability rating of 1 / 10.